Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luke S P Moore

Showing results (81-90 of 116) with videos related to

Pageof 12
Sort By:
Diagnostic Microbiology and Infectious Disease|September 9, 2022
Early identification of high-risk individuals for monoclonal antibody therapy and prophylaxis is feasible by SARS-CoV-2 anti-spike antibody specific lateral flow assayScott J C Pallett, Michael Rayment, Joseph Heskin, et al.
BMC Medicine|August 24, 2018
Quantifying where human acquisition of antibiotic resistance occurs: a mathematical modelling studyGwenan M Knight, Céire Costelloe, Sarah R Deeny, et al.
Journal of Health Economics and Outcomes Research|July 24, 2023
An Insurance Value Modeling Approach That Captures the Wider Value of a Novel Antimicrobial to Health Systems, Patients, and the PopulationMei S Chan, Richard Holloway, Robert King, et al.
Scientific Reports|June 9, 2016
Increased airway glucose increases airway bacterial load in hyperglycaemiaSimren K Gill, Kailyn Hui, Hugo Farne, et al.
Plos One|October 28, 2020
Investigating the association between ethnicity and health outcomes in SARS-CoV-2 in a London secondary care populationAatish Patel, Ahmed Abdulaal, David Ariyanayagam, et al.
Antimicrobial Resistance and Infection Control|March 24, 2018
Development of a patient-centred intervention to improve knowledge and understanding of antibiotic therapy in secondary careTimothy M Rawson, Luke S P Moore, Enrique Castro-Sanchez, et al.
Mycoses|December 14, 2020
A pseudo-outbreak of Rhinocladiella similis in a bronchoscopy unit of a tertiary care teaching hospital in London, United KingdomAlireza Abdolrasouli, Malick M Gibani, Theun de Groot, et al.
Frontiers in Microbiology|October 9, 2018
Surveillance for Azole-Resistant <i>Aspergillus fumigatus</i> in a Centralized Diagnostic Mycology Service, London, United Kingdom, 1998-2017Alireza Abdolrasouli, Michael A Petrou, Hyun Park, et al.
The Journal of Infection|January 4, 2017
Vancomycin therapy in secondary care; investigating factors that impact therapeutic target attainmentTimothy M Rawson, Esmita Charani, Luke S P Moore, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 25, 2024
Public Health Benefits of Applying Evidence-Based Best Practices in Managing Patients Hospitalized for COVID-19Andre C Kalil, Aastha Chandak, Luke S P Moore, et al.
Pageof 12

Showing results (81-90 of 116) with videos related to

Sort By:
Pageof 12
Diagnostic Microbiology and Infectious Disease|September 9, 2022
Early identification of high-risk individuals for monoclonal antibody therapy and prophylaxis is feasible by SARS-CoV-2 anti-spike antibody specific lateral flow assayScott J C Pallett, Michael Rayment, Joseph Heskin, et al.
BMC Medicine|August 24, 2018
Quantifying where human acquisition of antibiotic resistance occurs: a mathematical modelling studyGwenan M Knight, Céire Costelloe, Sarah R Deeny, et al.
Journal of Health Economics and Outcomes Research|July 24, 2023
An Insurance Value Modeling Approach That Captures the Wider Value of a Novel Antimicrobial to Health Systems, Patients, and the PopulationMei S Chan, Richard Holloway, Robert King, et al.
Scientific Reports|June 9, 2016
Increased airway glucose increases airway bacterial load in hyperglycaemiaSimren K Gill, Kailyn Hui, Hugo Farne, et al.
Plos One|October 28, 2020
Investigating the association between ethnicity and health outcomes in SARS-CoV-2 in a London secondary care populationAatish Patel, Ahmed Abdulaal, David Ariyanayagam, et al.
Antimicrobial Resistance and Infection Control|March 24, 2018
Development of a patient-centred intervention to improve knowledge and understanding of antibiotic therapy in secondary careTimothy M Rawson, Luke S P Moore, Enrique Castro-Sanchez, et al.
Mycoses|December 14, 2020
A pseudo-outbreak of Rhinocladiella similis in a bronchoscopy unit of a tertiary care teaching hospital in London, United KingdomAlireza Abdolrasouli, Malick M Gibani, Theun de Groot, et al.
Frontiers in Microbiology|October 9, 2018
Surveillance for Azole-Resistant <i>Aspergillus fumigatus</i> in a Centralized Diagnostic Mycology Service, London, United Kingdom, 1998-2017Alireza Abdolrasouli, Michael A Petrou, Hyun Park, et al.
The Journal of Infection|January 4, 2017
Vancomycin therapy in secondary care; investigating factors that impact therapeutic target attainmentTimothy M Rawson, Esmita Charani, Luke S P Moore, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 25, 2024
Public Health Benefits of Applying Evidence-Based Best Practices in Managing Patients Hospitalized for COVID-19Andre C Kalil, Aastha Chandak, Luke S P Moore, et al.
Pageof 12